Business ❯ Pharmaceutical Industry

Partnerships

Investment Research and Development Licensing Agreements Telehealth Collaboration Agreements Collaborations Generic Manufacturing BioArctic and Eisai Product Development Mark Cuban

Roche and Nurix Strike $700M Deal to Co‑Develop Oral BTK Degrader Bexobrutideg

Roche’s global scale will accelerate Phase 3 testing to advance the BTK degrader toward wider patient use.

BullFrog AI Strikes Top-5 Pharma Deal To Find Depression Drug Targets

Abbott to Commercialize Novo Nordisk’s Semaglutide in India Under Extensior Brand

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

FDA Grants Priority Review to Leqembi Autoinjector for Weekly At-Home Starting Dose

Novo Nordisk Expands Aspect Partnership, Transfers Diabetes Cell Tech as Aspect Takes Lead

Illumina Launches Billion Cell Atlas to Train AI in Drug Discovery

GSK and Ionis Report Phase 3 Success for Hepatitis B Drug, Plan Q1 Filings

Gujarat to Launch Indian AI Research Organization at GIFT City on Jan. 1, 2026

AstraZeneca’s LATIFY Phase 3 Finds No Survival Benefit for Ceralasertib Plus Imfinzi in Pre-Treated NSCLC

Sanofi Secures Global Rights to ADEL’s Alzheimer’s Antibody in Deal Worth Up to $1.04 Billion

Regeneron, Tessera Strike $150 Million Gene-Editing Pact for Alpha‑1 Antitrypsin Deficiency

UK Approves Once-Every-Four-Weeks IV Maintenance Dosing for Leqembi in Early Alzheimer’s

Novo Nordisk Slashes Wegovy Price in India by Up to 37% to Take On Mounjaro

Lilly Licenses MeiraGTx Eye Gene Therapy in Deal Worth Up to $475 Million

Lilly Taps Walmart for First Retail Pickup of Discounted Zepbound Vials Starting Mid-November

Lilly Taps Cipla to Market Tirzepatide as ‘Yurpeak’ in India at Mounjaro Price Parity

Novo Nordisk Taps Eurofarma to Launch Two Weekly Semaglutide Brands in Brazil

Glenmark Stock Hits Record High on $700 Million AbbVie Cancer Drug Deal

PTC Therapeutics and Novartis Sign $3 Billion Deal for Huntington's Disease Drug Development